UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000010681
Receipt number R000012488
Scientific Title Multicenter randomized phase II study of cisplatin+pemetrexed+bevacizmab followed by maintenance pemetrexied with or without bevacizmab in patients chemoterapy-naive advanced non-squamous non-small cell lung cancer with wild type EGFR(TORG1321)
Date of disclosure of the study information 2013/05/17
Last modified on 2021/11/08 11:07:55

No. Disposal Last modified on Item of update
1 Insert 2013/05/09 14:57:39
2 Update 2013/11/11 12:52:49 Email
Last name of contact person
Last name of contact person
Address
Email
3 Update 2014/06/09 10:23:37 Organization
Organization
Address
Address
TEL
Email
Last name of contact person
Last name of contact person
Organization
Organization
Division name
Division name
Address
Address
TEL
Email
4 Update 2014/07/18 10:39:25 Email
5 Update 2014/11/11 13:12:37 Name of person sending information
Name of person sending information
Email1
6 Update 2015/11/11 14:38:31 Randomization unit
Control
Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
7 Update 2016/05/09 09:08:06 Name of primary person or sponsor
Organization
Organization
Category of Funding Organization
8 Update 2019/04/24 09:27:19 Recruitment status
Date of IRB
Last follow-up date
9 Update 2020/11/26 09:57:37 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Zip code
Address
Address
TEL
Email

Last name of contact person

Last name of contact person
Zip code
Address
Address
Email
Address
Email3
Organization
Organization
Address
Address
Tel
Email
10 Update 2020/11/26 09:58:40 Date of closure to data entry
Date trial data considered complete
Date analysis concluded
11 Update 2021/11/08 11:07:55 Number of participants that the trial has enrolled